New Approach Methodologies (NAMs)

Summary

The FDA is advancing New Approach Methodologies (NAMs) to reduce, replace, or refine animal testing in drug safety evaluation with human-relevant methods. This is a regulatory initiative focused on improving prediction of drug efficacy in humans.